your badges 52W Range $28–$155 54% of range Analyst Rating BUY 10 analysts Price Target $267 +175% upside P/E -10.8 ROE -365.9% Net Profit Margin -10773.5%

INBX Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $96.99
Market Cap (MRQ) $1.43B
P/E -10.8
EPS $-9.04
Revenue $1M
ROE -365.9%
Debt/Equity (MRQ) -3.3
52W Range $28–$155

INBX Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$1M
2023-12-31 → 2025-12-31
EPS$-9.04
2023-12-31 → 2025-12-31
Free Cash Flow$-130M
2024-12-31 → 2025-12-31
Net margin-10773.5%
2024-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend INBX 5Y avg Peer Median Verdict
P/E -10.8 · · ·
P/S 1089.9 · 9.6 Overvalued
P/B (MRQ) -26.9 · · ·
EV / EBITDA -10.5 · · ·
Price / FCF (TTM) -10.8 · · ·
Price / Cash Flow (TTM) -10.8 · · ·
EV / Revenue 1071.7 · · ·
EV / FCF -10.7 · · ·
Price / Tangible Book 177.3 · · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise -1.6%
Next Report Nov 12, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Aug 13, 2026 $-2.34 $-2.44 4.0%
March 31, 2026 May 14, 2026 $-2.15 $-1.82 -18.0%
Dec. 31, 2025 $-2.11 $-2.12 0.40%
Sept. 30, 2025 $-2.28 $-1.75 -30.1%
June 30, 2025 $-1.85 $-2.82 34.3%
March 31, 2025 $-2.80 $-2.90 3.3%
Dec. 31, 2024 $-3.09 $-2.94 -5.0%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 14
Metric Trend 202520242023
Revenue $1M$200.0K$2M
R&D Expense $113M$204M$192M
SG&A Expense $23M$128M$29M
Operating Expenses $136M$332M$221M
Operating Income $-135M$-331M$-219M
Other Non-op $-381.0K$75.0K$-580.0K
Pretax Income $-140M$1.69B$-240M
Income Tax $2.0K$2.0K$3.0K
Net Income $-140M$1.69B$-241M
EPS (Basic) $-9.04$114.01$-20.48
EPS (Diluted) $-9.04$112.62$-20.48
Shares (Basic) 15,487,00014,802,00011,783,000
Shares (Diluted) 15,487,00014,984,00011,783,000
EBITDA $-133M$-329M·
Balance Sheet 21
Metric Trend 202520242023
Cash & Equivalents $124M$153M$278M
Prepaid Expense $8M$7M$17M
Other Current Assets $238.0K$382.0K$366.0K
Current Assets $133M$160M$295M
PP&E (Net) $4M$6M$6M
PP&E (Gross) $15M$15M$13M
Accum. Depreciation $11M$9M$7M
Other Non-current Assets $4M$7M$3M
Total Assets $146M$181M$308M
Accounts Payable $6M$9M$11M
Accrued Liabilities $26M$30M$43M
Current Liabilities $34M$41M$56M
Capital Leases $4M$6M$1M
Total Liabilities $138M$47M$264M
Total Debt $101M$0·
Common Stock $1.0K$1.0K$5.0K
Paid-in Capital $254M$240M$657M
Retained Earnings $-246M$-106M$-614M
Stockholders' Equity $8M$134M$44M
Liabilities + Equity $146M$181M$308M
Shares Outstanding 14,577,60914,476,00047,369,000
Cash Flow 10
Metric Trend 202520242023
D&A $2M$2M$1M
Stock-based Comp $11M$59M$25M
Other Non-cash $-3M$-1.94B·
Operating Cash Flow $-130M$-194M$-193M
CapEx $31.0K$3M$5M
Investing Cash Flow $-28.0K$-3M$-5M
Financing Cash Flow $101M$72M$202M
Net Change in Cash $-28M$-125M$4M
Taxes Paid $2.0K$2.0K$3.0K
Free Cash Flow $-130M$-197M·
Profitability 7
Metric Trend 202520242023
Operating Margin -10386.5%-165724.0%·
Net Margin -10773.5%843786.0%·
Pretax Margin -10773.3%843787.0%·
EBITDA Margin -10195.5%-164581.5%·
ROA -85.6%690.7%·
ROE -365.9%1081.6%·
ROIC -124.4%-248.1%·
Liquidity & Solvency 4
Metric Trend 202520242023
Current Ratio 3.93.9·
Quick Ratio 3.73.7·
Debt / Equity 12.60.0·
LT Debt / Equity 12.60.0·
Efficiency 1
Metric Trend 202520242023
Asset Turnover 0.00.0·
Per Share 5
Metric Trend 202520242023
Book Value / Share $0.55$9.23·
Revenue / Share $0.08$0.01·
Cash Flow / Share $-8.38$-12.97·
Cash / Share $8.52$10.54·
EPS (TTM) $-9.04$112.62·
Growth Rates 1
Metric Trend 202520242023
Revenue YoY 550.0%-88.9%·
Valuation (TTM) 14
Metric Trend 202520242023
Revenue TTM $1M$200.0K·
Net Income TTM $-140M$1.69B·
Market Cap $1.15B$223M·
Enterprise Value $1.13B$70M·
P/E -8.70.1·
P/S 885.91114.6·
P/B 144.11.7·
P / Tangible Book 144.11.7·
P / Cash Flow -8.9-1.1·
P / FCF -8.9-1.1·
EV / EBITDA -8.5-0.2·
EV / FCF -8.7-0.4·
EV / Revenue 867.7351.7·
Earnings Yield -11.4%731.3%·

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-31
Revenue $1M $200.0K $2M
Operating Margin % -10386.5% -165724.0% ·
Net Income $-140M $1.69B $-241M
Diluted EPS $-9.04 $112.62 $-20.48

Institutional owners (13F) 178 filers · $1.4B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 178
Value held $1.4B
New positions 49
Exited positions 19
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
49 (+21 vs prior Q) 19 (-6 vs prior Q) 61 (+7 vs prior Q) 41 (+1 vs prior Q) +1.6M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
MORGAN STANLEY $123,937,898 1,308,051 8.63% Shares
PERCEPTIVE ADVISORS LLC $122,963,044 1,297,763 8.56% Shares
Sanofi $109,713,489 1,157,926 7.64% Shares
VIKING GLOBAL INVESTORS LP $106,492,273 1,123,929 7.41% Shares
HighTower Advisors, LLC $82,484,676 870,551 5.74% Shares
BANK OF AMERICA CORP /DE/ $79,698,110 841,141 5.55% Shares
BlackRock, Inc. $78,260,825 825,972 5.45% Shares
Schonfeld Strategic Advisors LLC $66,096,272 697,586 4.60% Shares
STATE STREET CORP $60,683,396 640,458 4.22% Shares
VANGUARD GROUP INC $49,223,636 623,084 3.43% Shares
VANGUARD CAPITAL MANAGEMENT LLC $46,662,196 492,477 3.25% Shares
Woodline Partners LP $37,984,517 400,892 2.64% Shares
Capital Research Global Investors $34,398,988 363,050 2.39% Shares
GOLDMAN SACHS GROUP INC $32,042,176 338,176 2.23% Shares
PFM Health Sciences, LP $29,219,479 308,385 2.03% Shares
Sofinnova Investments, Inc. $28,719,009 303,103 2.00% Shares
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $25,743,575 271,700 1.79% Shares
Parkman Healthcare Partners LLC $24,346,013 256,950 1.69% Shares
GEODE CAPITAL MANAGEMENT, LLC $24,278,247 256,175 1.69% Shares
First Turn Management, LLC $15,613,189 164,783 1.09% Shares
MILLENNIUM MANAGEMENT LLC $13,947,200 147,200 0.97% Shares
CDC Financial, Inc. $13,277,318 140,130 0.92% Shares
FIRST TRUST ADVISORS LP $12,168,174 128,424 0.85% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $11,612,276 122,557 0.81% Shares
CAPITOLIS LIQUID GLOBAL MARKETS LLC $11,294,200 119,200 0.79% Shares
NORTHERN TRUST CORP $9,565,676 100,957 0.67% Shares
NORGES BANK $8,555,925 90,300 0.60% Shares
CITIGROUP INC $7,174,565 75,721 0.50% Shares
Jefferies Financial Group Inc. $6,956,166 73,416 0.48% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $6,840,950 72,200 0.48% Call option
VANGUARD FIDUCIARY TRUST CO $6,624,920 69,920 0.46% Shares
GOLDMAN SACHS GROUP INC $6,300,875 66,500 0.44% Call option
RENAISSANCE TECHNOLOGIES LLC $5,893,545 62,201 0.41% Shares
EVENTIDE ASSET MANAGEMENT, LLC $5,831,389 61,545 0.41% Shares
BNP PARIBAS FINANCIAL MARKETS $5,669,935 59,841 0.39% Shares
Voleon Capital Management LP $5,529,421 58,358 0.38% Shares
VOLORIDGE INVESTMENT MANAGEMENT, LLC $4,620,484 48,765 0.32% Shares
Western Standard LLC $4,453,250 47,000 0.31% Shares
NOMURA HOLDINGS INC $3,837,375 40,500 0.27% Call option
Caption Management, LLC $3,827,900 40,400 0.27% Call option
CITADEL ADVISORS LLC $3,534,175 37,300 0.25% Call option
VICTORY CAPITAL MANAGEMENT INC $3,452,974 36,443 0.24% Shares
ArrowMark Colorado Holdings LLC $3,332,926 35,176 0.23% Shares
UBS Group AG $3,318,050 35,019 0.23% Shares
HUSSMAN STRATEGIC ADVISORS, INC. $2,984,625 31,500 0.21% Shares
Empyrean Capital Partners, LP $2,842,500 30,000 0.20% Shares
CDC Financial, Inc. $2,842,500 30,000 0.20% Call option
Atom Investors LP $2,804,032 29,594 0.20% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $2,717,241 28,678 0.19% Shares
Corient Private Wealth LP $2,714,873 28,653 0.19% Shares

Show all 178 institutional owners →

Activists & 5%+ owners 2 positions

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
The Jon F. Kayyem and Paige Gates-Kayyem Family Trust, Jon Faiz Kayyem ×2 filings Feb. 26, 2025 7.90% Amendment · SEC
Mark Lappe ×2 filings Feb. 26, 2025 6.40% Amendment · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 9 insiders · 4 officers · 5 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
Mark Lappe Chief Executive Officer Sept. 28, 2026 P 740,548 10 0 $3,644,153
Kelly Deck Chief Financial Officer April 1, 2025 A · 0 0 $0
David Matly President April 24, 2026 A · 0 0 $0
Brendan P. Eckelman Chief Scientific Officer May 30, 2024 A 40,000 0 0 $0
Jon Faiz Kayyem Director Sept. 23, 2026 P 434,360 3 0 $1,567,600
Kristiina Vuori MD Director June 3, 2026 A 20,443 0 0 $0
Douglas Forsyth Director June 3, 2026 A 227,064 1 0 $286,625
Kimberly Manhard Director June 3, 2026 A 7,500 0 5 $-279,015
Inhibrx, Inc. 10% owner May 29, 2024 J 1,157,926 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 28 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
BBC · ETFis Series Trust I 0.60% 3,371 NS July 31, 2026 N-PORT
FYC · First Trust Exchange-Traded AlphaDE… 0.47% 74,091 NS July 31, 2026 N-PORT
LABU · Direxion Shares ETF Trust 0.23% 13,627 NS July 31, 2026 N-PORT
FYX · First Trust Exchange-Traded AlphaDE… 0.22% 36,827 NS July 31, 2026 N-PORT
VFMO · VANGUARD WELLINGTON FUND 0.13% 27,554 SH Aug. 19, 2026 Daily
IBBQ · Invesco Exchange-Traded Fund Trust … 0.10% 1,036 SH Oct. 1, 2026 Daily
FAD · First Trust Exchange-Traded AlphaDE… 0.10% 6,714 NS July 31, 2026 N-PORT
IBB · iShares Trust 0.09% 82,742 SH Sept. 11, 2026 Daily
PWS · Pacer Funds Trust 0.06% 186 NS July 31, 2026 N-PORT
IWO · iShares Trust 0.06% 73,332 SH Sept. 11, 2026 Daily
VTWG · VANGUARD SCOTTSDALE FUNDS 0.04% 8,415 SH Aug. 19, 2026 Daily
PRFZ · Invesco Exchange-Traded Fund Trust 0.04% 10,484 SH Oct. 1, 2026 Daily
IWM · iShares Trust 0.04% 244,961 SH Sept. 11, 2026 Daily
ISCG · iShares Trust 0.03% 2,913 SH Sept. 9, 2026 Daily
VTWO · VANGUARD SCOTTSDALE FUNDS 0.03% 54,768 SH Aug. 19, 2026 Daily
RSSL · Global X Funds 0.03% 4,552 NS July 31, 2026 N-PORT
VXF · VANGUARD INDEX FUNDS 0.01% 110,905 SH Aug. 19, 2026 Daily
VTWV · VANGUARD SCOTTSDALE FUNDS 0.01% 1,460 SH Aug. 19, 2026 Daily
VHT · VANGUARD WORLD FUND 0.01% 20,879 SH Aug. 19, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.01% 3,429 NS July 31, 2026 N-PORT
WSML · iShares Trust 0.01% 467 SH Sept. 10, 2026 Daily
ITOT · iShares Trust 0.00% 13,967 SH Sept. 11, 2026 Daily
IWV · iShares Trust 0.00% 1,963 SH Sept. 9, 2026 Daily
RYLD · Global X Funds 0.00% 15,798 NS July 31, 2026 N-PORT
VTI · VANGUARD INDEX FUNDS 0.00% 369,641 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.00% 781 SH Aug. 19, 2026 Daily
IWN · iShares Trust · 16,842 SH Sept. 11, 2026 Daily
ISCB · iShares Trust · 398 SH Sept. 11, 2026 Daily

INBX Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 10 analysts BUY
Median target $245.00 +152.6%
3 30.0% Strong Buy
5 50.0% Buy
2 20.0% Hold
0 0.0% Sell
0 0.0% Strong Sell

12-Month Price Target

3 analysts · 2026-09-28

Mean target $266.67 +174.9%

← Below all targets Current price $96.99
Low$230.00 Mean$266.67 High$325.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
INBX $1.15B -8.7 550.0% -10773.5% -365.9% ·
SNDX $1.84B -6.4 627.8% -165.6% -257.1% ·
TSHA $1.57B -16.2 17.3% -1115.3% -44.0% ·
RARE $2.22B -3.9 20.2% -85.4% -1613.2% ·
ANAB · -105.4 157.0% · · ·
COAG · · · · · ·
TYRA $1.41B -13.1 · · -42.7% ·
AVBP $854M -4.7 · · -59.7% ·
KLRA · · · · · ·
ORIC $806M -5.6 · · -36.5% ·

Latest News Recent headlines mentioning this company

23
Inhibrx Biosciences (INBX) Announces Positive Interim Results From Phase 2 Portion of HexAgon Study Yahoo Finance · 4 months, 2 weeks ago

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Aug 13, 2026